Home Bratislava Medical Journal 2022 Bratislava Medical Journal Vol.123, No.5, p.326–333, 2022

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.2

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.123, No.5, p.326–333, 2022

Title: Is amniopatch an effective treatment for spontaneous previable premature rupture of membranes? Analysis of perinatal outcome
Author: Martin ALFOLDI, Peter PAPCUN, Marian KRIZKO, Martin GABOR, Michaela FERIANCOVA, Juraj GAZDARICA, Vladimir FERIANEC

Abstract: OBJECTIVES: To characterize the perinatal outcomes of pregnancies complicated by spontaneous previable premature rupture of membranes with a therapeutic intervention in the form of amniopatch (AP) at the 2nd Department of Obstetrics and Gynecology (2008‒2019).
MATERIALS AND METHODS: The retrospective analysis of perinatal markers and early neonatal morbidity of pregnancies treated with amniopatch. Discussion comparison with the published papers of cases of spontaneous previable rupture of membranes managed expectantly.
RESULTS: Out of the total number of pregnancies, 53 met the exclusion criteria, of which 35 were terminated by delivering a live newborn, 3 newborns died during the hospitalization. The following incidence of early complications has been reported in live births: 1) Bronchopulmonary dysplasia (10/35–28.57 %), 2) Newborn respiratory distress syndrome (25/35–71.42 %), 3) Neonatal sepsis (15/35–42.85 %), 4) Intraventricular hemorrhage (14/35–40 %), 5) Periventricular leukomalacia (3/35–8.57 %), 6). Necrotizing enterocolitis (2/35–5.71 %), 7) Retinopathy of prematurity (7/35–20 %) and 8) Foetal compression syndrome (16/35–45.71 %). In a discussion comparison with available publications of expectantly managed pregnancies, we observed a statistically significantly lower incidence of respiratory distress syndrome, retinopathy, and chorioamnionitis in our cohort along with a higher incidence of foetal compression defects.
CONCLUSION: Amniopatch can be a therapeutic method for reducing the neonatal mortality associated with RDS, maternal infectious morbidity, and an alternative in patients, who require an active approach to such a compromised pregnancy (Tab. 12, Fig. 1, Ref. 50).

Keywords: spontaneous previable rupture of membranes, amniopatch, expectant management, perinatal morbidity, perinatal mortality
Published online: 14-Apr-2022
Year: 2022, Volume: 123, Issue: 5 Page From: 326, Page To: 333
doi:10.4149/BLL_2022_051


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.